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The Genetic Toxicity Database ofthe
National Toxicology Program: Evaluation
of the Relationships between Genetic
Toxicity and Carcinogenicity
by Raymond W. Tennant*
ThedatabaseoftheU.S. NationalIbxicolog Progmhasbeendevelopedoverapproximatelytwodecades,principally
focusedonsubstancesevaluatedforcardnogenicity inrodentbiossays. Theseassaysgenenllyprovidedataontherelative
toxicityandcarcinogenicityofchemicalsbasedupondiscretesubchronic (13week)andchronic(104week)exposures. A
majorvalueofthesedataarethattheassayprotocols, rodentstrains, andtechnicalmethodologieshavebeengenerally
consistent, thus permitting comparisons between assays and chemicals. The genotoxicity data for many ofthe same
chemicals have been developed also using standardid biological systems and protocols Data for assays including
mutagenicity in Salmonella and mouse lymphoma cells, chromosomal aberrations, and sisterchromatid exchange in
Chinesehamsterovarycells,tansf ofBalb/c313cells,andin wvocytogeneticeffectsinrodentshavebeencompiled
formanychemicals. Theresultsofalloftheseassaysprovideasubstantialdatabase forevaluatingchemicaleffectsand
fordefining thecomplex relationships betweenmutagenicity andcarcinogenicity.
Introduction
Thegenetictoxicity databaseoftheU.S. NationalToxicology
Program (NTP) has evolved over approximately a 10-year
period. Thedatabase was anindirectproductofeffortstodevelop
andevaluate methods todetect mutagens andidentify potential
carcinogens. Thelattergoal waspredominantbecausethedura-
tionandcostofidentifyingcarcinogensthroughanimalbioassays
mandates thatothermethodsbesoughttoreducedependence on
thebioassay.
The efforts ofother organizations such as the International
ProgramforChemical Safety (IPCS)andtheU.S. Environmen-
tal ProtectionAgency (EPA) toconducttheir ownevaluationsof
methods toidentify carcinogens ledtotherealizationthat a con-
certed effort to develop in vitro genetic toxicity data was man-
datory if an evaluation was ultimately to have any influence on
the use of in vitro or in vivo short-term tests (STTs). Results
emergingfromtheIPCSandEPAstudiesindicatedthenecessity
ofdeveloping assayprotocolsthatcouldyield atleastqualitative-
ly reproducible results within and between laboratories. This
goal was generallly achievedby the NTPbyhaving two or more
laboratories testidentical chemicals that were submitted under
code. The useoffixedprotocolsandcodedchemicals, however,
createthedisadvantagethat assays cannotbeadapted tospecific
chemical properties such as solubility, volatility, osmolarity,
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pH, etc. However, theobjectivevalueofthedataobtainedbythe
assay of coded chemicals was judged to outweigh the other
limitations. Theprincipal sourceoferrorintroducedbytheuse
of coded chemicals is that while a positive response may be
definitive, anegativeresponsemightbeconditionalandcouldbe
changedby amoreappropriate assayprotocol. However, since
mostoftheassaysevaluatedby theNTPwere subjectedtocod-
edchemicals, itmaybeassumedthattherewasaconsistentbias
forall ofthe STTs.
Another result of the IPCS and EPA studies was the dem-
onstration that too few ofthe chemicals had been tested in all
systems and that there was an inadequate number of noncar-
cinogens tested in any STT. In this regard, the NTP rodent
bioassay database provided the most appropriate source of
chemicals to meetthesedeficiencies. Some specific aspects of
thedataneedtobeemphasizedinrelationshiptothegenetic tox-
icity database.
Overthepasttwodecades, therodentcarcinogenicity studies
conductedbytheNationalInstitutesofHealthhavebeengeneral-
lyconsistentinregardtotheassayprotocols, strainsofrodents,
characterization ofchemicals, andtheuseofabiologically ac-
tive dose, the so-called maximum tolerated dose or MTD.
Despite controversy overthe selectionofthe MTD, itprovides
amethodofadministeringchemicalsatadosethathasbiological
activity, regardlessofwhetherachemicalishighlyorweaklytox-
ic. Because of the above factors, it is possible to make com-
parisons within and between chemicals and bioassay results.
Therearemorethan300chemicalsthathavebeentestedforcar-
cinogenicity inboth ratsandmice. BecauseabouthalfoftheseR. W. TENNANT
failedto induceasignificantcarcinogenicresponse,thisdatabase
provides aunique resource foroperationalnoncarcinogens. Itis
always possible thatadministrationofthesechemicalsby some
other route, atahigherdoseorlongerduration, orto someother
strains or species mightinduce acarcinogenic effect. However,
under conditions where many other chemicals were car-
cinogenic, thesechemicalsdid notinduceneoplasia. Inaddition,
for the carcinogenic chemicals, because of the above meth-
odologies, thepatterns, sites, andfrequencies oftumors induc-
ed in one orbothspecies are alsoimportant factors available for
evaluation. For the majority ofthe STT data compiled by the
NTP, thechemicalsevaluatedintherodentbioassayrepresentthe
unifying parameter.
Results
The data currently available for "unique" chemicals, thatis,
chemicals distinguished by a specific Chemical Abstracts Ser-
vice (CAS) Registry number, inboth in vitroandin vivo systems
are shown in Table 1. The data for each chemical and assay
system have been published or will be published in the near
future. The specific references reportingdata arelisted in Table
1 under the respective assay system. A number of reasons in-
fluenced the selectionoftheseparticular chemicals fortesting.
The usual reason wasthatthe chemical was proposedfor, orhad
been tested in, the NTP rodentbioassay. Other reasons includ-
ed chemical structure, unusualchemicalproperties, or interest
byothergovernmentagencies. The database, therefore, may or
may notbe representativeoftheuniverseofchemicals towhich
humans maybeexposed. Thelargestproportionofthechemicals
areofsynthetic originbuta significantpercentageareofnatural
origin. Thedataforallthein vitro systems, excepttheBalb/c3T3
transformation system, arecompiled inthe computer systemof
the National Institute of Environmental Health Sciences
(NIEHS). The data from the different test systems were either
entered atthetesting laboratory onfloppy diskandsubmittedto
the NIEHS computerorsubmitted ashardcopy reports withdata
entry onto the computerdone at NIEHS. A sample ofchemical
coded with a six-digit aliquot number was issued to the testing
laboratory from acentral repository. This sample was general-
ly fromthe samelotofchemical used or selected fortherodent
bioassay. (If the sample was used in a rodent bioassay, there
Table 1. Current statusofthe NTPgenetic toxicity database.
Number of
unique
Assay system chemicals References
In vitro
Salmonella mutagenesis 1662 (1-6)
Chinese hamster ovary cell (7-14)
Chromosome aberrations 606
Sister chromatidexchange 602
Mouse lymphomacell mutagenesis 343 (23-32)
BALB/c 3T3 cell transformation 200 (47-48)
In vivo
Drosophila mutagenesis (15-22)
Sex-linked recessive lethal assay 283
Reciprocal translocation 68
Rodent bone marrow (33-39)
Chromosomal aberrations 116 (33-39)
Sister chromatid exchange 116
Micronuclei 158
wasanextensiveanalysis forpurity and identity. Ifnotamong
chemicals chosenforbioassay, alimitedanalysis forpurity was
conducted.) Thisrepresentsanotheraspectoftheefforttoreduce
themany sourcesofvariability thatcancomplicatetheevalua-
tion ofboth chemicals and assay systems. Each in vitro assay
wasgenerally repeatedaccordingtotheestablishedprotocolfor
thespecific test system, which may include repeating positive
or negative responses; additional assays may be performed to
resolve anyproblems ininterpreting theoverall "call" foreach
aliquot. Aftertheoverallresultofeitherpositive, negative, or
equivocalismadeforeachaliquot, theidentityofthealiquotis
releasedbytherepositoryandthedatathencanbeaccessedfrom
thecomputerbyeitherchemical name, CAS number, orassay
system. Themajorityofthedatabasetestresultsforeachofthe
in vitroassayslistedinTable 1 havebeenpublished; thepublica-
tions are referenced in the table.
Oneotheraspectoftheprogram thatledto thedevelopment
ofthisdatabasedeservescommentary becauseitalsorelatesto
ensuring that the data obtained are of the highest quality
achievable under such a contract-testing approach. The lab-
oratories participating in the generation ofthese data operate
under the general guidelines for good laboratory practices
(GLPS). Because the standardized version of GLPs are not
directly applicableto in vitro testmethodsandbecauserepeat-
ability oftestresults was anintegral component ofthe in vitro
assayprotocols, theGLPsusedinthisprogramareamodifica-
tionofthoseendorsedbyothergovernmentagencies. However,
the fidelity ofdata transmission has been ensured by periodic
auditsofthemanytestinglaboratories. Inaddition, periodically
positiveandnegativecontrolchemicals were sentascodedali-
quotsalong withothertestchemicals tothetestinglaboratories
toensuretheintra-andinterlaboratoryreproducibilityofresults.
Theeffortstoensurethequalityofthegenetictoxicity assays
and the ability to relate the results ofthe assays directly to the
results ofthesamechemicalstested inrodentbioassaysmakes
it possible to conduct evaluations in which there can be con-
fidence that the conclusions may have general value. Genetic
toxicitydatafortwogroupsofchemicalswereusedinseparate
evaluationsofthecapacity offourin vitroassaystodistinguish
betweenrodentcarcinogensandnoncarcinogens. Thefirststudy
included 73 chemicals, and the latter study evaluated an addi-
tional 41 chemicals (40,41). The predictive value ofinduced
mutagenesis inSalmonellaandmouse lymphomacells and in-
ducedchromosomal aberrations and sisterchromatidexchanges
(SCEs) inCHOcells weresimilarforbothgroupsofchemicals.
The combined data sets were evaluated for the standard pa-
rameters ofassayperformance (sensitivity and specificity) and
the Salmonella assay which had the lowest sensitivity (0.48),
demonstrated the highest specificity (0.91). Conversely, the
mouselymphomamutagenesis assayhadthehighest sensitivi-
ty (0.72) butthelowestspecificity (0.40). Theoverall concor-
dance(accuracy) ofthefourassays were0.66, 0.61, 0.59, and
0.59forSalmonella, chromosomeaberrations, SCE, andmouse
lymphomacells, respectively. Forthesechemicals, Salmonella
mutagenesis had the bestpredictive value for carcinogenicity
(89%), but anegative response in any ofthese assays was not
predictive fornoncarcinogens. Itis importantto notethatthere
was no complementarity among these four in vitro assays and
thatnocombinationofthesefourassayswasmorepredictiveof
carcinogenic potential than the Salmonella assay alone.
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The above results indicate that these assays generally detect
similar chemical properties but thatotherchemical properties
can also be related to carcinogenic potential. An extensive
evaluation of the relationship between chemical structure,
mutagenicity, andcarcinogenicity hasshownthatthereisavery
highcorrelationbetweenspecificchemical substructures (struc-
turalalerts) andcarcinogenicpotential (42-46). Thesestructural
alerts thus represent specific riskfactorsforcarcinogenic poten-
tial that have high predictive value and are related to general
chemical classgroups. Chemicalsthatarecarcinogenic butfail
toshowevidenceofpotentialelectrophilic substructures repre-
sent a major challenge for future structure-activity analyses.
Thesenongenotoxic ornonmutageniccarcinogensarethefocus
ofextensive researchandattemptstodevelopnewassaysthatmay
reflect their carcinogenicpotential. The search for such assays
must includetheevaluation oftheeffectsofchemicals thatlack
mutagenicity (i.e., nostructuralalertsandarenotmutagenic to
Salmonella) and are noncarcinogens; a partial group of such
agents islisted inTable2. Itistobeemphasizedthatthesenon-
carcinogensareoperationally identified onthebasisofexposure
oftwo rodent species forup to 104 weeks to an MTD. Many of
these substances are relatively nontoxic and were thus ad-
ministeredtotheanimalsatrelativelyhighdoses. Thisisthemost
extensive listavailableofoperationally definednoncarcinogens
that lack structural alerts formutagenicity.
There isoneother importantcomponentoftheNTPdatabase
thatcanbeofgreatvalueinvalidating any newassayspurported
toidentify carcinogens. Therearecurrently about50substances
thatarein somephaseoftherodentbioassay. Thesephases range
from ongoing subchronic (i.e., 90 day) toxicity assays for
establishing an MTD level for the 2-year assays, to the 2-year
studiesnearingcompletion. Thecarcinogenicpotential forthese
agents is notnowknown, butitwillbeestablishedwithin a2-to
3-year period. Forty-four ofthese substances have been used
recently to prospectively evaluate the predictive potential of
structural alerts and Salmonella mutagenicity for identifying
carcinogens (44). Inaddition, becausenonmutagenic substances
are also included in this group, it was also an opportunity to
evaluatethepredictivevalueofsubchronicorgan-specific toxici-
ty. These samechemicalshavebeenused intwootherprediction
exercises with computer-based expert systems (43). These
substances under test represent a unique database that can be
used to significantly shorten the time and effort required to
evaluateandvalidate othermethodsofcharacterizing potential
carcinogens.
Discussion
Itmustbeemphasizedthatthegenetictoxicitydatabaseofthe
NTP will only continue to enlarge in specific areas. Limited
numbers ofnew chemicals arebeing tested formutagenicity in
Salmonellaandforchromosomal aberrations invitro andinvivo.
Theconceptofidentifying oneorafew invitro short-term tests
with which to screen large numbers of chemicals and to
specifically identify potential carcinogens has not been sup-
portedbythestudiescitedabove. TheNTPattemptstousestruc-
tural information, Salmonellamutagenicity, in viocytogenetic
effects, andselectedsubchronic toxicity results as riskfactors for
potentialcarcinogens. Thereisalsoacontinuingeffbrttodevelop
Table 2. Nonmutagenic noncarcinogens.
Acetohexamide
Aldicarb
o-Anthranilic acid
Benzoin
Butylated hydroxytoluene
Carbromal
Chlorpheniramine maleate
Chlorpropamide
C.I. Acid Red 14
Diarylanilide yellow
1,2-Dichlorobenzene
N,N'-Dicyclohexylthiourea
Ephedrine sulfate
Ethionamide
FD&C Yellow No. 6
Guargum
Lindane
Locust bean gum
Malathion
DL-Menthol
Methyl methacrylate
Pentachloronitrobenzene
Phenol
I-Phenyl-3-methyl-5-pyrazolone
I-Phenyl-2-thiourea
Phthalic anhydride
Sodiumdiethyldithiocarbamate
3-Sulfolene
2,3,5,6-Tetrachloro-4-nitroanisole
Tetraethylthiuram disulfide
Titanium dioxide
Tolbutamide
L-Tryptophan
Agar
Anilazine
L-Ascorbic acid
Benzyl alcohol
Caprolactam
2-Chloroethyltrimethylammonium Cl
3-Chloro-p-toluidine
C.I. Acid Orange 10
Coumaphos
Diazinon
Dichlorodiphenyltrichloroethane
Endrin
Erythromycin stearate
Ethylenediamine tetracetic acid
Geranyl acetate
Gum arabic
Lithocholic acid
Malaoxon
D-Mannitol
Methoxychlor
Penicillin VK
Phenformin
Phenylephrine HCI
N-Phenyl-p-phenylenediamine
Phthalamide
Piperonly butoxide
Sulfisoxazole
Tara gum
Tetracycline HCI
Tetrakis(hydroxymethyl)phos-
phonium Cl
Triphenyltin hydroxide
Xylenes, commercial mixture
otherin vitroandinvivomethodsthatidentifyotherriskfactors,
particularlyfornonmutagenic substances. Therearemajorim-
pediments to the exclusive use of multiple existing in vitro
systems, beyond the fact that they measure, with varying
specificity, somesimilarchemicalproperties. Theyoftencannot
accommodate the aspects ofmetabolism, disposition, chronic
exposureregimens, and specificchemical-gene interactions that
canplaycritical rolesinthemultistepormultigeneprocessesof
neoplasia. Databases such as those of the NTP are clearly
valuable in deducing relationships between structure and bio-
logical effects ofchemicals. However, databases are not con-
structivelyusedwhenappliedtoretrofitting results. Itisunlikely
thatanyexisting invitroassayswillemergeasusefulshort-term
tests from suchretrospectiveassociations. Timeand resources
will be muchbetter spentsearching fornew methodsofidenti-
fyingchemical propertiesthatcanbeetiologically linkedtocar-
cinogenesis. Suchmethodsmightincludethosethatcanidentify
indirect damage to critical cell functions through free radicals
resulting fromoxidativemetabolism; alterationofnormal recep-
tor-ligandfunctions; disruptionofsignaltransductionpathways;
oralterationofregulatoryfunctionsforgenetranscription. These
arenotnecessarilythemostappropriateandcertainlyare notthe
only important mechanisms that can be studied. They are,
however, mechanisms by which both electrophilic and non-
electrophilic substances could generate heritable phenotypic
changes.
There isoneotherimportantissuerelatedtothedevelopment
ofdatabases. An important factor in the conclusions that have
been reachedabouttherelationship between in vitro short-term
testsandrodentcarcinogenicity studieshasbeentheavailability
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ofdataonrodentnoncarcinogens. Anequally important factor
ineffortstounderstandtheextendedrelationshipsbetweenthese
rodentorin vitrodataandtheriskofinducedcarcinogenesisin
humans istheabsenceofadatabaseonsubstancesthatarepro-
bably notcarcinogenic tohumans. Withouttheability todeter-
minetheeffects ofsuch substances inassays thatare supposed
todetectcarcinogenicpotential, therewillcontinuetobeuncer-
tainty and controversy about weak and equivocal effects of
chemicals. If nothing can be judged to be probably noncar-
cinogenic forhumans, thentherewillcontinuetobecontrover-
sy about weakly positive substances identified ascarcinogens.
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